Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Chardan, we identified genetic medicines as an exemplar of disruptive innovation about 5 years ago. Since that time, we have built the leading global coverage in the space, with 28 names under coverage. We are able to uncover the next big thing ahead of the rest of Wall Street because of our strong scientific foundation—evident in our industry-leading frameworks and weekly pieces—and our independent voice. Our influence...
At Chardan, we identified genetic medicines as an exemplar of disruptive innovation about 5 years ago. Since that time, we have built the leading global coverage in the space, with 28 names under coverage. We are able to uncover the next big thing ahead of the rest of Wall Street because of our strong scientific foundation—evident in our industry-leading frameworks and weekly pieces—and our independent voice. Our influence extends beyond printed research to our hosted conferences, where we bring together the best companies, investors, and other industry innovators around the world.

List your booth number for exhibitions, ask us